Toggle light / dark theme

Billionaire Elon Musk on Saturday asked his Twitter followers to decide whether he should sell 10% of his Tesla stock, promising to “abide by the results of this poll, whichever way it goes.”

“Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock,” the electric car maker’s CEO said. He did not directly specify where that 10% would go.

This isn’t the first time Musk has taken aim at proposals in Washington that would tax billionaires’ net worth gains. Under current US tax law, assets like stocks are taxed only when they’re sold — what’s called a capital gain. But the richest of the rich in America probably aren’t selling off their massive stock portfolios; instead, their main form of income is the value that those assets accrue, or unrealized gains.

A new database aims to make it easier than ever to access and search through the world’s massive trove of research papers.

Each year, millions of scientific and academic papers get published across thousands of journals. The majority of those papers lie behind paywalls, costing $9 to $30 (or more) to read. Finding them can be difficult: Tools like Google Scholar allow you to search for paper titles and keywords, but more specialized queries are difficult.

The General Index was designed to reduce those obstacles without breaking the law. Developed by the technologist Carl Malamud and his nonprofit foundation Public Resource, the free-to-use index contains words and phrases from more than 107 million research papers, comprising 8.5 terabytes when compressed.

Jeff Bezos’ space company Blue Origin has lost a lawsuit against NASA it filed over the agency’s decision to award a $2.9 billion contract to Elon Musk’s rocket company SpaceX to build a lunar lander to transport astronauts to the Moon, according to a federal court ruling Thursday.

The lucrative contract was given to SpaceX in April as part of NASA’s Artemis program that aims to fly the first woman and first person of color on the Moon by 2024. SpaceX was selected to develop… See more.

Federal judge Richard A. Hertling ruled in favor of SpaceX, concluding a sealed complaint Blue Origin filed in the U.S. Court of Federal Claims in August, and said a protective order to seal documents in the lawsuit would remain in effect.

The ruling comes amid a heated billionaire space race between Blue Origin, SpaceX and billionaire Richard Branson’s Virgin Galactic.

Blue Origin took legal action against NASA saying the agency was “unlawful and improper” in its evaluation of three proposals for the lunar lander contract, including ones from Dynetics and Blue Origin.

Samsung’s next big product according to them seems to be a revolutionary neuromorphic computing chip which is attempting to enable Artificial Intelligence models to become as smart as humans. The top leading AI scientists are expecting for AI models to outpace the rate of moores law which means we’ll need to design new kinds of processors and computer chips beyond silicon. That’s where Samsung’s Brain of a Chip approach is supposed to help. It would be a chip that mimics the brain in terms of performance and power consumption which is called Neuromorphic chip design or computing and is believed to be the future of Artificial Intelligence.

If you enjoyed this video, please consider rating this video and subscribing to our channel for more frequent uploads. Thank you! smile

00:00 Samsung’s new Path forward for AI
01:10 The History of AI-Hardware.
02:01 What are Neuromorphic Processors?
04:25 What could this enable?
06:40 So what’s the future of AI Computing?
09:06 Last Words.

#samsung #ai #chip

Visit our sponsor, Brilliant:
Artificial Intelligence offers many challenges, including criminals using AI to break the law, but also of AI, robots, and androids becoming criminals themselves.

Visit our Website:
Support us on Patreon:
Facebook Group:
Twitter: on Twitter and RT our future content.
SFIA Discord Server:

Listen or Download the audio of this episode from Soundcloud: Episode’s Audio-only version:
Episode’s Narration-only version:

Criminal AI
Science & Futurism with Isaac Arthur.
Episode 314 October 28 2021

Written by:
Isaac Arthur.
Jerry Guern.

Produced & narrated by isaac arthur.

Yahoo has shut down access to its services in China, becoming the latest American tech company to exit the country.

It pulled the plug “in recognition of the increasingly challenging business and legal environment,” a Yahoo spokesperson said in a statement.

“Yahoo remains committed to the rights of our users and a free and open internet. We thank our users for their support.”

This company’s entry in the US; market; along with other aluminum giants is said to have caused the shutdown of a large number of Aluminum manufacturers based in the US. It seemed that local US companies were unable to compete with state backed companies which were taking advantage of the free trade agreement.

However, the trade tariffs along with recent events have in turn caused this firm to become insolvent. It’s founder is now being detained by the US under fraud charges.

China Zhongwang Holdings Limited is known as the “King of Aluminum in Asia. On October 15th, China Zhongwang suddenly announced its subsidiaries “had suffered significant losses and operational difficulties. Despite efforts from various parties, they are unable to solve the current problems on their own.” The two subsidiaries mentioned are the primary companies of the corporate business.
The debt crisis of Chinese companies is spreading, which can bring about a serious financial crisis in China. For example, China’s big business conglomerate, Baoneng Group, has experienced increasing strain on its capital chain. Currently, it has defaulted on at least nine items of trusts, involving a total of about $3.1 billion US dollars. Moreover, it has seen a rising risk factor for its subsidiaries, with frequent news about equity pledges, property freezes, and legal proceedings.

Have questions? Do you have something to share with us about China? We want to hear from you!
Email: [email protected]

Copyright @ China Insights 2021. Any illegal reproduction of this content in any form will result in immediate action against the person(s) concerned.

As the world turns increasingly more digital and data-driven, there is an increasing desire for greater visibility and transparency of data. Governments around the world have turned to digital means to submit and pay taxes as well as collect a variety of revenue from different sources. Likewise, governments are making deeper use of data and systems for their expenditures and analyzing the patterns of that spending.

One of the lesser-known agencies in the US federal government is the Bureau of the Fiscal Service (BFS). As a bureau of the U.S. Department of the Treasury, the BSF manages the federal government’s accounting, central payment systems, and public debt. In essence, the BFS is the bookkeeper for the US federal government. A huge role given the trillions of dollars that flow through US coffers on an annual basis. Since the Federal Funding Accountability and Transparency Act of 2006 (FFATA) was signed into law on September 26 2006, the BFS has embarked on a number of wide ranging data-centric efforts to provide visibility into government spending including,, and

Not surprisingly, the BFS has also invested heavily in the use of AI, the main topic of an upcoming AI in Government presentation on November 18 2021 with Justin Marsico, Chief Data Officer of the Bureau of the Fiscal Service. In that presentation, Justin shares how deeply the bureau is investing in the use of AI and some of the ways in which it is providing insights into government spending and revenues.

AI & computational technology for improving drug discovery & development — mati gill, CEO, AION labs.

Mati Gill is the Chief Executive Officer, of AION Labs (, a company recently launched and backed by a coalition of pharma and tech leaders, including AstraZeneca, Merck, Pfizer, Teva, Amazon Web Services (AWS), and the Israel Biotech Fund (IBF) and Israel Innovation Authority, to improve the whole drug discovery & drug development process with AI and computational biology.

Mati has an MBA (Healthcare & Innovation) and BS degree in law from Reichman University / IDC Herzliya, and has over a decade of experience in leadership roles in the biopharma industry, including most recently as Head of Government Affairs, Corporate & International Markets, at Teva Pharmaceuticals.

Mati also spent 4 years as Member Of The Board Of Advisors and Directors, at Sanara Ventures, a healthcare investment platform backed by Philips & Teva, providing Pre-seed, Seed and A round financing to young companies.

Prior to teva, mati was chief of staff to israel’s minister of public security.